written on 22.05.2014
Tags:
,

Pharmstandard nabs Russia's Biocad, with a little oligarch aid

TAGS: ,

Last year, multinational drugmakers had their eyes on Russian biosimilars developer Biocad. But now, it's the country's own lead pharma company that will grab the St. Petersburg-based company.

Latest Report